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Abstract  
IMPLICTIONS OF VESTIBULAR DYSFUNCTION  
AMONG THE AGING POPULATION  
A Pocket Guide for Health Care Professionals  
 
by 
 
Maia Weisenfeld 
Advisor: Dr. Barbara Weinstein, Ph.D.  
 
The goal of this health information booklet is to provide healthcare professionals with the appropriate 
tools and information required to ensure all patients with a vestibular impairment are cared for and treated 
appropriately. The following guide includes overview of the vestibular system, vestibulotoxic 
medications, and common vestibular disorders. These notable areas are required for appropriate treatment 
and referral to other professionals for treatment.   
Keywords: vestibular dysfunction, central pathology, peripheral pathology, vestibulotoxicity, balance 
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Introduction 
By the year 2030, it is estimated that 20% of the United States population will be persons 
aged 65 and over. From 2000 to 2010 alone this age group grew 15% from 35 million to 40.3 
million. This increasing population will have a substantial effect on the health care system, 
particularly emergency medicine.  From 2009 to 2010, a total of 19.6 million emergency 
department visits in the United States were made by persons aged 65 and over.  Of those visits, 
29% were related to injury and an even higher percentage for those aged 85 and over (Albert, 
McCaig & Ashman, 2013).  In the United States, unintentional falls are the most common cause 
of nonfatal injuries for people older than 65 years (Currie, 2008). Falls have a positive 
correlation with age. As a result, the number of emergency department visits for falls increases 
with age.  
Vestibular dysfunction and a degenerating vestibular system can lead to falls.  Postural 
control is mediated by input arising from the visual proprioceptive and vestibular systems. 
Altered function of these systems with increasing age may lead to impaired balance and 
increased falls risk in older adults (Liston et al., 2014). As reported by Agrawal et al. (2009), 
persons with vestibular dysfunction are more likely to report dizziness or a history of falls. In 
their study, 26.8% of participants with known vestibular dysfunction had an 8-fold increase in 
the odds of falling. Among those participants aged 80 years and older, the odds of falling were 7-
fold higher compared to the participants in their 40s.  
An important finding in the study performed by Liston et al (2014) was that 80% of older 
adults with a history of falls had an unidentified vestibular impairment. Additionally, report of 
dizziness and/or vertigo increased with age. Vestibular vertigo was noted to be three times more 
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frequent among the older participants than the younger participants.  Unexplained fall related 
injuries in the emergency department have been associated with vestibular complaints as 
vestibular disorders significantly decrease balance therefore increasing the likelihood of falls 
(Alghadir, Iqbal & Whitney, 2012).  
According to Currie (2008), up to 32 percent of community-dwelling individuals over the 
age of 65 fall each year. For those 65 years of age and older, fall-related injuries are the most 
common cause of accidental death, resulting in approximately 41 fall-related deaths per 100,000 
people per year (Currie, 2008). In conjunction with the catastrophic numbers of falls, injuries 
related to falls and deaths related to falls, the increased medical attention and reduced autonomy 
for persons over 65 years is a societal toll that must be addressed. When appropriately diagnosed 
and referred to fall risk-reduction programs, the US Centers for Disease Control reported 
effectiveness in reducing the risk of falls in community-dwelling older adults (Zuniga et al., 
2012).  
In addition to a degenerating vestibular system, the aging process is also known to impact 
the auditory system resulting in hearing loss. Hearing loss has been associated with increased 
risk of falls. Those individuals with hearing loss are noted to have 2.39 times greater odds of 
falling than those without hearing loss (Jiam, Li & Agrawal, 2013). More specifically, hearing 
loss is noted to be significantly correlated with reduced saccular function. As a result, older 
individuals with high-frequency hearing loss should be screened for fall risks. This screening 
should consist of vestibular evaluations including cervical vestibular evoked myogenic potentials 
(Zuniga et al., 2012).  
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These findings have important clinical implications for the assessment and rehabilitation 
of the aging population.  The British and American Geriatrics Society joint guideline for falls 
prevention recommends a balance, gait and mobility assessment however vestibular testing is not 
explicitly incorporated (Liston et al., 2014). Those presenting to the emergency department or 
other healthcare office who have difficulty ambulating, history of falls or symptoms of dizziness 
and/or vertigo should always be examined for a peripheral or central vestibular impairment 
(Alghadir, Iqbal & Whitney, 2012). As reported by Zamergrad et al., (2017), a staggering 74-
81% of peripheral vestibular disorders are not appropriately diagnosed. Referring to audiologists 
and/or other balance specialists is the first step in addressing these problems.  
Once appropriately evaluated, those with vestibular dysfunction can be referred for 
treatment/management. Approximately 50-80% of those who receive vestibular rehabilitation 
achieve significant symptom, gait and postural stability improvements (Liston et al., 2014). 
Improvements in quality of life have also resulted from vestibular rehabilitation (Alghadir, Iqbal 
& Whitney, 2012). By increasing awareness and education of healthcare professionals such as 
nurses, nurse practitioners, physician assistants, residents and medical doctors in emergency 
medical settings as well as general practices, appropriate assessment and treatment can reduce 
the catastrophic toll that falls, and vestibular dysfunction have on those aged 65 and over. To 
fully understand the impairments, background knowledge on the vestibular system, vestibular 
disorders and vestibulotoxic medications is pertinent for medical professionals.  
 
  
4 
 
The Vestibular System  
 
 
 
 
 
 
 
The vestibular system is divided into two separate but conjoining systems: the peripheral 
vestibular system and the central vestibular system. Together, these systems are responsible for 
sensing motion of the head, maintaining postural control, and providing stability of images 
during motion. The peripheral vestibular system is more commonly referred to when referencing 
dizziness or vertigo. It is located in the petrous portion of the temporal bone, which lies in the 
otic capsule.  Housed within this region are the bony and membranous labyrinths of the 
peripheral vestibular system.  
THE BONY LABYRINTH THE MEMBRANOUS LABYRINTH 
• Cochlea 
• Vestibule 
• Semicircular Canals 
• Contains perilymph 
• Cochlear Duct 
• Otoliths 
o Saccule 
o Utricle 
• Semicircular Canal Ducts 
• Contains endolymph 
Figure 1. The bony and membranous labyrinths of the inner ear. 
Table 1. Structures of the bony and membranous labyrinths. 
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The vestibular portion of the eighth cranial nerve – the vestibulocochlear nerve, 
innervates the peripheral vestibular system. This vestibular nerve has two branches: the superior 
vestibular nerve and the inferior vestibular nerve (Khan & Chang, 2013). Proper function of the 
superior and inferior 
branches is necessary to 
maintain function of the 
semicircular canals, the 
utricle and the saccule.   
A primary function of the peripheral vestibular system is to detect head acceleration. The 
semicircular canals are responsible for angular acceleration while the otoliths are responsible for 
linear acceleration (Day & Fitzpatrick, 2005). The semicircular canals are oriented roughly 90 
degrees from one another with the lateral semicircular canal titled approximately 30 degrees 
backwards. Located at the end of each semicircular canal is a bulge known as the ampulla. 
Within this bulge is the cupula – a gelatinous structure that houses the crista ampullaris. The 
crista ampullaris is a cone like structure that contains hair cells needed to detect rotational head 
movement (Khan & Chang, 2013). This type of movement is known as angular acceleration. For 
example, when the head turns 
right, hair cells in the right lateral 
semicircular canal are excited 
while hair cells in the left lateral 
semicircular canal are inhibited. 
This alerts the brain that the head 
is turning right, not left. 
Figure 2. Superior and Inferior Vestibular Nerve innervation. 
Figure 3. Cupula deflection during angular acceleration.  
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The saccule and utricle are responsible for linear acceleration - that is, how the head 
moves with respect to gravity (ex: tilting forwards). Stereocilia and kinocilium of sensory hair 
cells are embedded within otolithic membrane, a gel like structure, which lies superior to the 
maculae. Located within the otolithic membrane are calcium carbonate crystals called otoconia. 
The otoconia provide internal mass to the otolithic organs. This increases the specific gravity 
above that of the endolymph resulting in the maculae of the otolithic organs being responsive to 
linear acceleration (Khan & 
Chang, 2013). When the head 
moves up or down, be it a 
person sits up or lies down, 
the otoconia are displaced 
leading to excitation of the 
utricle and saccule.   
Dysfunction at any point in the peripheral vestibular system can lead to imbalance, 
dizziness, vision illusions or falls. As healthcare professionals, it is our responsibility to identify 
a patient who may suffer from vestibular dysfunction. Unfortunately, the signals are not always 
obvious and concomitant problems lead to unidentified vestibular issues or misdiagnoses.   
 
 
 
  
Figure 4. Deflection of kinocilium and stereocilia during linear 
acceleration.  
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The Aging Vestibular System  
The bony labyrinth undergoes degenerative changes as the body ages. Sensory receptors 
(hair cells) decrease in number and peripheral neural fibers are reduced. The saccule and utricle 
lose about 25 percent of their hair cells whereas the semicircular canals lose about 40 percent. 
Beginning around the age of 40, the number of neurons and the size of the neurons that make up 
the vestibular nucleus decrease by 3 percent each decade. This decline in vestibular sensory cells 
and neural pathways result in age-related reduction in vestibular afferent signals sent and 
received by the central nervous system (Anson & Jeka, 2016).  
Functional consequences of fewer sensory cells in the semicircular canals and otolithic 
organs are reduced sensitivity to gravitational and linear acceleration associated with head and 
body position. Reduced saccular function has been linked to age related changes in gait speed in 
healthy older adults.  A reduction of these sensitivities in the aging vestibular system may 
contribute to slower walking as a self-protective strategy to prevent falls in older adults (Anson 
& Jeka, 2016). Approximately one third to one half of the population over 65 experiences an 
injurious fall annually; 80 percent of falls in a study by Liston et al. (2014) were found to have 
vestibular origin. These falls most commonly occur when walking or sitting/standing due to high 
head acceleration.  
The vestibular system is linked to visuospatial function. As these systems deteriorate, 
elderly individuals have trouble with proprioception and spatial navigation. For accurate spatial 
awareness, the vestibular system must be intact to serve as an egocentric reference frame. As 
their systems age, older adults lose the accuracy of this reference frame. As a result, they have 
greater difficulty integrating multisensory cues for navigation. This leads to increased difficulty 
walking or standing on uneven or soft surfaces, especially in poorly lit environments.  Body 
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sway increases and may be partially responsible for general postural unsteadiness (especially 
falls). Equilibrium and balance become impaired especially when fast movement is required 
(Anson & Jeka, 2016). Older adults generally adapt by moving slowly and walking with a wide 
stance with their feet apart gait to provide greater stability.   
How to Assess the Balance and Gait of Your Patients 
Both informal and formal evaluations can be used to assess a patient’s balance and gait. 
Informally, the following are things to note during a patient’s visit: 
Does the patient need assistance rising from their chair? YES/NO 
Does the patient need assistance walking? (Ex: stops to touch the wall or 
chair) 
YES/NO 
Does the patient use a cane or walker? YES/NO 
Is the patient’s gait fluid and continuous? YES/NO 
Does the patient wear appropriate footwear? YES/NO 
 
Formally, the Tinetti Balance and Gait Test is a useful assessment tool. Listed below is the 
grading scale for both balance and gait. A score of 22 or below indicates a patient is at risk.  
Balance Score  
Instructions: Patient is seated in a hard armless chair.   
Sitting balance 
- Leans or slides in chair = 0 
- Steady = 1  
 
Arise 
- Unable without help = 0 
- Able but uses arms to help = 1 
- Able without use of arms = 2 
 
Table 2. Informal Observations 
Table 3. Tinetti Balance and Gait Test. Balance questionnaire.  
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Attempts to rise 
- Unable without help = 0 
- Able, but requires more than one attempt = 1 
- Able to rise with one attempt = 2 
 
Immediate standing balance (first 5 seconds) 
- Unsteady (staggers, moves feet), marked trunk sway = 0 
- Steady but uses walker or cane or grabs other object for support = 1 
- Steady without support = 2 
 
Standing balance 
- Unsteady = 0 
- Steady, but wide stance or uses cane or other support = 1 
- Narrow stance without support = 2 
 
Nudge (Patient stands with feet close together, examiner pushes lightly on subject’s sternum with palm 
of hand 3 times) 
- Begins to fall = 0 
- Staggers but catches self = 1 
- Steady = 2 
 
Eyes closed (Same position as number 6) 
- Unsteady = 0 
- Steady = 1  
 
Turn 360 degrees 
- Discontinuous steps = 0 
- Continuous steps = 1 
- Steady = 2  
 
Sit down 
- Unsafe, misjudged distance, falls into chair = 0 
- Uses arms or not a smooth motion = 1 
- Safe, smooth motion = 2 
 
Total  
 
Gait Score  
Instructions: Patient stands with examiner, walks down the hall or across the room at 
their usual pace and then back at a rapid pace. Distance should be approximately 25 
feet.  
 
Initiation of gait (immediately after told “go”) 
- Hesitancy at start = 0 
 
Table 4. Tinetti Balance and Gait Test. Gait questionnaire.  
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- No hesitancy = 1 
Step length and height 
Right foot swing 
- Does not pass L stance foot with step = 0 
- Passes L stance foot =1  
- R foot does not clear floor completely with step = 0 
- R foot completely clears floor = 1 
Left foot swing 
- Does not pass R stance foot with step = 0 
- Passes R stance foot =1  
- L foot does not clear floor completely with step = 0 
- L foot completely clears floor = 1 
 
Step symmetry 
- R and L step length not equal = 0 
- R and L step appear equal = 1 
 
Step continuity 
- Stopping or discontinuity between steps = 0 
- Continuous steps = 1 
 
Path 
- Marked deviation = 0 
- Mild/moderate deviation or uses walking aid = 1 
- Straight without walking aid = 2 
 
Trunk 
- Marked sway or uses walking aid = 0 
- No sway but flexion of knees or back, or spreads arms out while walking = 1 
- No sway, flexion, arm spread, or walking aid = 2 
 
Walk stance  
- Heels apart = 0 
- Heels almost touching while walking = 1 
 
Total  
Total Balance + Total Gait  ____/ 28 
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Cognitive and Emotional Ailments and the Aging Vestibular System 
In addition to physical ailments associated with vestibular dysfunction in the aging 
population, cognitive and emotional ailments are present among this population. Decline in 
cognition is widely associated with the aging population. Of lesser awareness is the associated 
between the aging vestibular system and mental health. Older adults are more likely to have 
anxiety, depression and a fear of falling in light of these vestibular changes. For patients who 
complain of dizziness, there is a three-time greater prevalence of self-reported anxiety and a 
higher incidence of depression than those who do not complain of dizziness (MacDowell et al., 
2017). Vestibular dysfunction has also been noted to mediate the decline in cognition typically 
associated with older age (Anson & Jeka, 2016).  The vestibular system makes important 
contributions to areas of cognitive function including: spatial awareness, memory, attention and 
executive function. Older adults with known vestibular lesions will often complain of memory 
loss or “brain fog” (Semenov et al., 2016).  Smith et al. (2005) reported that 95% of older adults 
with confirmed a confirmed perilymph fistula and/or benign paroxysmal positional vertigo 
(commonly referred to as BPPV) had long-term “disorientation” due to their lack of visuospatial 
awareness. Of the same population, 85% reported memory loss. Auditory processing deficits 
have also been related to older individuals with vestibular impairments (Smith et al., 2005).   
In a study by Semenov et al. (2016), older adults with vestibular symptoms had increased 
difficulty with activities of daily living. As a result, quality of life is reduced due to limited 
independence secondary to vestibular impairments. Unfortunately, there seems to be difficulties 
in the ability to identify patients that are considered “high risk” for falls. This difficulty may 
come from older adults’ tendencies to overstate their own competence in completing daily tasks. 
12 
 
For example, many older individuals will say they have no difficulty getting out of bed or rising 
from a chair. However, when observed clinically, they struggle with these tasks (Cohen, 2011).  
To improve quality of life for the 
aging population, these areas of concern 
must be addressed. Awareness of the 
implications that vestibular impairments 
can have on the aging adult is pertinent in 
correctly diagnosing, treating and 
supporting these patients.  
 
Hearing Loss and the Aging Vestibular System 
As previously noted, older adults with vestibular impairments struggle with mental health 
and cognition. Hearing loss is a widely known health concern for the aging population that is 
also related to decreased quality of life, reduced cognitive ability, poor emotional status and 
increased fear of falling. Older adults with hearing loss have 2.39 times greater odds of falling 
than their normal hearing counterparts (Jiam, Li & Agrawal, 2016). More than that, the National 
Health and Nutrition Examinations survey (2001-2004) reported that for every 10 dB of hearing 
loss, risk of falling increasing 1.4 times (Rumalla, Karim & Hullar, 2014). The association 
between hearing loss and falls has been linked to reduced spatial awareness due to the loss of 
auditory perception, a reduction in cognitive capacity given the cognitive load of hearing loss, 
and the presence of comorbid auditory and vestibular pathologies (Jiam, Li & Agrawal, 2016). 
Due to the close anatomical proximity, older adults with degenerating vestibular systems 
are likely to have degenerating auditory systems. Adults aged 70 years and older with hearing 
As hearing 
sensitivity and 
vestibular 
function 
decrease..
Risk of falls and 
associated 
emotional 
consequences 
increase
Figure 5. Relationship between hearing loss and vestibular 
impairment with risk of falls and fear of falling.  
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loss are more likely to have reduced saccular function (Zuniga et al., 2012). In the study by 
Zuniga et al., (2012), white adult males with history of smoking and noise exposure were the 
most likely to have high frequency sensorineural hearing loss and saccular dysfunction. Because 
of these findings, it is recommended that older adult patients should be screened for fall risks. 
This screening should include referral to audiology for hearing evaluations and balance testing 
including cervical vestibular evoked myogenic potential (cVEMP) evaluation to determine 
saccular involvement.  
Following a hearing test, hearing instruments have been reported to be effective in not 
only improving auditory awareness and increasing quality of life but in improving patient’s 
balance as well. Vestibular, visual and proprioceptive inputs are critical in maintaining balance 
(Shayman, Earheart & Hullar, 2017). The auditory stimulation serves as spatial orienting 
landmarks to increase balance and reduce risk of falls. In addition to auditory stimulation, 
hearing instruments have been considered to have alerting effects on older individuals and have 
caused them to be more aware of their surroundings reducing their risk of falling (Stevens, 
Barbour, Gronski & Hullar, 2016).  
 
  
Figure 6. Effects of hearing instruments on falls 
Hearing 
instruments 
Increased spatial 
and auditory 
awareness
Reduced risk of 
falling 
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Vestibular Disorders 
Dizziness is a common symptom that is reported to affect more than 90 million 
Americans. It is also the most common complaint of patients aged 75 and older (Thompson & 
Amedee, 2009). The term dizziness is an umbrella term that is frequently used to describe 
various sensations. Understanding the type of dizziness described will allow health care 
professionals to better understand their patient’s symptoms to determine the appropriate 
intervention and treatment. Ross and Robinson (1984) classified dizziness in four ways: 
Disequilibrium A sense of imbalance. Characterized by difficulties walking. Present 
in Parkinson or Alzheimer’s patients. 
Presyncope/faintness A feeling of impending loss of consciousness.  Often caused by 
circulatory insufficiency. Anemia, thyroid diseases, hypoglycemia 
and medical problems that lessen oxygenation of the brain contribute 
to faintness. 
Lightheadedness Likely caused by multiple sensory deficits, anxiety with 
hyperventilation and chronic systemic disease 
Vertigo A sensation of rotating or spinning in space. The illusion that one is 
moving, or their surroundings are moving is characteristic of vertigo 
and differentiates the symptom from other forms of dizziness. 
 
Sample Questions to Ask Your Patients 
✓ What does your dizziness feel like? 
✓ Do you feel the room or environment spins or are you spinning? 
✓ Do you feel like you may fall-down? 
✓ Do nausea and vomiting occur at the same time? 
✓ How often does it occur? 
✓ Does it occur with movement? 
✓ Did you have a change in medication at the onset? 
✓ Do you have a history of migraines or motion sickness? 
Table 5. Classification of Dizziness.   
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In addition to straight forward questions, open ended questions will allow you to have a 
better understanding of your patient’s symptoms. Symptoms of dizziness or imbalance may be 
the result of numerous impairments including vision, proprioception, musculoskeletal, or 
vestibular dysfunction (Agrawal et al., 2009). An estimated 30-35% of older adults suffer from 
vestibular dysfunction (Anson & Jeka, 2016). Vestibular dysfunction can occur in the peripheral 
and central vestibular systems. Awareness of the manifestations and differences between the 
various disorders is critical in appropriate evaluation and treatment. The following section will 
discuss common vestibular disorders of both the peripheral and central vestibular systems.  
  
16 
 
Peripheral Vestibular Disorders  
Benign Paroxysmal Position Vertigo  
 Considered the most common peripheral vestibular disorder, Benign Paroxysmal 
Positional Vertigo (BPPV) is reported to affect a staggering 64 of 100,000 Americans 
(Froehling, Silverstein, Mohr, et al., 1991). Although it can occur at any time, BPPV typically 
appears in the fourth to fifth decades of life (Thompson & Amedee, 2009). Women are two times 
more likely to experience BPPV than men. While 95% of cases are considered to be degenerative 
or idiopathic, of those cases that are symptomatic, 17% result from head injury and 15% result 
from vestibular neuritis. BPPV has also been linked to patient with ailments causing them to be 
bed ridden or sedative (Brandt et al., 2013).  
BPPV occurs when some of the otoconia become displaced and migrate into one or more 
of the semicircular canals. During head movement, the otoconia float within the semicircular 
canals. This movement displaces the endolymph causing deflection of the cupula. This deflection 
is detected by the brain and in return elicits sensation of perceived movement. This perception 
results in rapid eye movement - called nystagmus – and vertigo. Patients who are affect by BPPV 
frequently complain of intense, sudden spinning sensation that is often elicited by rolling over in 
bed, rising from a sitting position, or turning their head quickly (Thompson & Amedee, 2009). 
There are two types of BPPV: Canalithiasis and Cupulothiasis. Determining the type of BBPV 
an individual is experiencing is important in determining the appropriate treatment.  
Canalithiasis also known as “Typical BPPV” is the most common form of this pathology. 
When the head is moved with respect to gravity, the otoconia settle at the lowest portion of the 
inner ear – the posterior semicircular canal. The involvement of this posterior semicircular canal 
is the defining feature of Canalithiasis. The right posterior semicircular canal is more frequently 
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affected than the left (Brandt et al, 2013). Canalithiasis is characterized by geotropic nystagmus 
with the problem ear down, transient nystagmus (typically less than 20 seconds), reversal of 
nystagmus with movement in the opposite direction, and fatigue of nystagmus and subjective 
vertigo upon repetition of the movement. 
 
 
Cupulothiasis is the less common form of BPPV, accounting for approximately 5% of all 
cases. With Cupulothiasis, otoconia are not free floating but instead attach to the cupula within 
the inner ear (Lee & Kim, 2010). When the head is moved, the additional weight on the otoconia 
cause symptoms characteristic of BPPV. Geotropic nystagmus with the problem ear down and 
severe vertigo is also typical of Cupulothiasis however; symptoms are noted to last longer than 
60 seconds.  
Canalithiosis
Symptoms  under 
one minute 
(typically less 
than 20 seconds)
BPPV
evoked by 
movement
geotropic 
nystagmus with 
problem ear down
severe vertigo
Cupulothisis
Symptoms lasting 
one minute or 
greater
Figure 7. Symptoms of Benign Paroxysmal Positional Vertigo and subtypes.   
Figure 8. Displacement of otoconia in Cupulothiasis BBPV and Canalithiosis BPPV.   
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Although BPPV may resolve on its own, it may persist in 30% of patients (Brandt et al., 
2013). Appropriate identification of the structures involved (typically obtained during a through 
medical history) is key in recommended the proper treatment/management. According to Li, Li, 
Epley & Weinberg (2000), the costs of BPPV are reported to be more than $2,000 per individual. 
Most of these expenses are the result of inappropriate diagnostic procedures and ineffective 
therapies. Referral to an audiologist for proper diagnostic evaluation such as the Dix Hallpike 
Maneuver is recommended. During the Dix 
Hallpike Maneuver, the patient is asked to 
turn their head 45 degrees to one side and 
then the patient lies back quickly with 
support from the audiologist. Once back, 
their head will hang supported over the 
edge of the bed/chair. Eye movements are then observed and recorded using appropriate 
equipment. The patient is then returned to upright position. If there is an increase in rapid eye 
movements (nystagmus), the procedure is repeated on that side. The same process is then 
performed on the other side.  
Following diagnosis, referral to a specialist for canalith repositioning maneuvers (such as 
the Epley maneuver, Semont’s liberatory maneuver or Brandt–Daroff maneuver) is the key 
component in management. The most common repositioning technique is the Epley maneuver. 
This is a series of head movements performed in sequence to position. If the patient has a history 
of neck or back problems, evaluation and management should be recommended with caution.   
 
 
Figure 9. Performance of the Dix Hallpike 
Maneuver   
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Meniere’s Disease 
Also known as primary endolymphatic hydrops, Meniere’s disease is a disorder of the 
membranous labyrinth of the inner resulting from disruption in the flow of endolymphatic fluid 
(National Institute on Deafness and Other Communication Disorders, 2017). Endolymph is 
derived from the stria vascularis and flows through the scala media, up the ductus reuniens into 
the saccule and eventually into the endolymphatic sac. The endolymphatic sac acts as an 
immuno-defense of the ear. It is responsible for reabsorption of the water content in endolymph 
as well as removal of metabolic and cellular debris. A disruption at any point in the 
endolymphatic pathway can lead to hearing and balance 
problems.  
While the exact cause of Meniere’s disease is 
unknown, possible etiologies include:  hyper secretion of 
endolymph from the stria vascularis, under absorption of 
endolymph caused by failure of the endolymphatic sac, or 
blockage of the endolymphatic ducts, utricular duct, 
saccular duct and/or ductus reuniens (Coelho & Lalwani, 
2008). Other factors that may affect the excess of 
endolymph include abnormal immune response, viral 
infection, head trauma, migraines, and allergies – 
Meniere's disease symptoms occur more frequently in autumn and spring. One in five patients 
with confirmed Meniere’s disease have a positive family history suggesting a genetic 
predisposition to the disorder. Overall, there is a multifactorial predisposition to Meniere’s 
disease (Da Costa et al., 2002).  
Figure 10. Healthy inner ear vs. pathologic 
inner ear affected by Meniere’s disease.  
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The classic triad of symptoms of Meniere’s disease includes vertigo, hearing loss and 
tinnitus. However, this classic triad is only seen in 27% of patients. The fourth common 
symptom of Meniere’s disease is aural fullness.  In many patients, auditory symptoms alone or 
vestibular symptoms alone precede the development of the full-blown symptomatic disease for 
many months or years. In the natural progression of the disease, tinnitus and fluctuating hearing 
loss may present years before a vertigo episode. Purely vestibular attacks without cochlear 
symptoms are relatively uncommon but can be the initial manifestation at the beginning of the 
disease. However, since vertigo is often the most alarming symptom, its appearance is frequently 
regarded as the onset of the disease. The variation in symptoms is attributed to the four sub-
classifications of Meniere’s disease (Da Costa et al., 2002).  
CLASSICAL 
MENIERE’S 
DISEASE 
BILATERAL 
MENIERE’S 
DISEASE 
VESTIBULAR 
MENIERE’S 
DISEASE 
COCHLEAR 
MENIERE’S 
DISEASE 
Episodic vertigo 
Sensorineural hearing 
loss 
Tinnitus 
Aural fullness 
Typically unilateral 
Bilateral fluctuating   
Recurrent episodes of 
vertigo 
Often develops 
asymptomatically 
Vertigo attacks identical 
to Classic Meniere’s 
Hearing remains normal 
Tinnitus and aural 
fullness may or may not 
be present 
Fluctuating and 
progressive hearing loss 
Tinnitus and aural 
fullness are present 
Vertigo is absent 
 
 
Hearing loss associated with Meniere’s disease generally presents as progressive, 
fluctuating, sensorineural hearing loss in one ear. Most commonly, audiometric configuration 
begins in the low frequencies and progresses into the high frequencies where it may eventually 
become a flat hearing loss to varying degree. In addition to hearing loss, those affected by 
Meniere’s disease frequently report tinnitus in the affected ear. Most commonly, tinnitus is 
Table 6. Classification of Meniere’s Disease.   
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described as a low-pitch, roaring sound. Aural fullness or aural pressure is also a frequent 
complaint. While this sensation is typically felt in the ear, it may spread to any part of the head 
or even the neck. Those with Meniere’s disease may also complain of hyperacusis or diplacusis. 
Hyperacusis is an increased sensitivity to sound. Those with hyperacusis may perceive every 
day, normal sounds to be unbearably loud. Diplacusis is described as “double hearing,” where 
someone may perceive a sound in a different pitch or at a different time in either ear. 
Hyperacusis and diplacusis symptoms are often worse after an episode of Meniere’s disease. 
Some can have a condition known as Lermoyez syndrome. In these patients, there is a 
paradoxical improvement in hearing following an acute attack. In many cases, tinnitus and 
hearing loss are common precursors before the first attack of vertigo (Da Costa et al., 2002). 
Vestibular symptoms typically manifest as episodic vertigo also called vertigo attacks. 
The vertigo sensation can vary between affected individuals. In some cases, severe vertigo can 
cause nausea and/or vomiting. In other cases, vertigo can be a feeling of imbalance that lasts a 
long time and occurs in between attacks. Positional vertigo (described under Benign Paroxysmal 
Positional Vertigo) can exacerbate or occur between attacks. In rare cases, vestibular symptoms 
are so explosive that the patient falls to the ground. These are referred to as “falling spells of 
Tumarkin” or more commonly, drop attacks.  The duration of vestibular attacks will vary 
between patients. In 50% of cases, vertigo attacks last less than one hour – commonly 20 
minutes. In 25% of cases, attacks can last between one to two hours. In the remaining 25% of 
cases, attacks can last from two hours to one day. The number of vestibular attacks is reported to 
range from 3 to over 30 attacks per year per individual (Paparella, Costa, Fox & Yoo, 1991).  
Referral to an otolaryngologist and audiologist are recommended for diagnosis and 
management of symptoms. Baseline and sequential hearing tests are recommended due to the 
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progressive nature of hearing loss associated with Meniere’s disease. Hearing instruments may 
beneficial depending on the severity of loss and impact on daily life. Electrocochleography may 
be performed by an audiologist to identify Meniere’s disease however, test sensitivity is highly 
dependent on the test being performed during an acute attack. Additionally, balance testing and 
referral to physical therapy for vestibular rehabilitation can provide patients with compensatory 
strategies. 
Unfortunately, there is no specific cure or treatment for Meniere’s disease. Lifestyle 
modifications such as the CATSS method is often recommended. CATSS includes limiting 
caffeine, alcohol, tobacco, salt and stress. Diuretics, antihistamines, anticholinergics, anti-nausea 
and anti-vert medications may be taken to varying levels of success to help alleviate symptoms 
(Da Costa et al., 2002). For those with severe symptoms that are debilitating, surgical options 
such as vestibular neurectomy, labyrinthectomy and endolymphatic sac surgery are available. As 
with all surgeries, each has their own risk. With vestibular neurectomy and labyrinthectomy, the 
patient must be willing to accept associated side effects such as complete loss of function on the 
affected side. Despite being less effective in alleviating symptoms than the previously mentioned 
surgical options, endolymphatic sac surgery is the preferred initial surgical intervention for 
Meniere’s disease (Kim, Wiet & Battista, 2005). However, like the disease itself, treatment will 
vary patient to patient. Understanding the patient’s daily life and their needs will aid in this 
decision.  
Vestibular Neuritis 
 Following BPPV and Meniere’s disease, vestibular neuritis is the third most common 
cause of peripheral vestibular dysfunction. Strupp and Brandt (2009) reported an annual 
incidence of 3.5 per 100,000 persons. Vestibular neuritis is the inflammation of the inner ear as a 
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result of an infection that enters the vestibular portion of the eighth cranial nerve. The superior 
vestibular nerve is most commonly involved due to its location within the internal auditory canal. 
As a result, it is more susceptible to compressive edema (Thompson & Amedee, 2009). Patients 
may report an upper respiratory infection or other ailment a few days or even weeks prior to the 
onset of symptoms.  
 Patients affected by vestibular neuritis experience sudden vertigo that is often 
accompanied by nausea and vomiting. In addition, patients presenting with vestibular neuritis 
typically have gait deviation and tendency to fall. If the lesion is unilateral, patients will typically 
fall to the affected side (Brandt et al., 2013).  Tinnitus and aural fullness may also accompany 
vertiginous symptoms. While neuritis has symptoms similar to other vestibular disorders, hearing 
loss is not a symptom of vestibular neuritis. Sudden hearing loss is a differentiating factor 
between neuritis and labyrinthitis. It is important to ask a patient presenting with symptoms if 
hearing loss was present prior to current symptoms. 
 Diagnosis of vestibular neuritis is one of exclusion. For this reason, an extensive history 
is required. Physical examination is limited given the varying symptoms. A complete 
audiological evaluation including videonystagmography/electronystagmography (VNG/ENG) 
and vestibular evoked myogenic potentials (VEMPs) is highly recommended to determine site of 
lesion. After diagnosis, treatment is also limited. Symptoms may gradually improve but complete 
spontaneous recovery is unlikely (Brandt et al., 2013). Anti-vertigo and anti-nausea medications 
will be helpful for patient comfort, but long-term use may inhibit compensation.  Encouraging 
patients to ambulate as soon as possible will promote recovery. Ambulation with support (canes, 
walkers, etc.) is recommended. Unfortunately, recurrence of vestibular neuritis is not uncommon.  
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Labyrinthitis   
 Similar to vestibular neuritis, labyrinthitis is the inflammation of the inner ear as the 
result of an infection. This particular infection affects the membranous labyrinth therefore 
resulting in cochlear and vestibular involvement. Bacteria or viruses can result in labyrinthitis. 
Due to antibiotics, bacterial labyrinthitis is less common (Bertholon & Karkas, 2016). Common 
viral etiologies include adenovirus, respiratory syncytial virus (RSV), influenza, herpes virus, 
hepatitis, polio, cytomegalovirus (CMV), Epstein‐Barr virus, measles, rubella, and mumps. In 
addition, chronic middle ear infections can result in labyrinthitis (Herendeen, 2007). 
Presentation is similar to vestibular neuritis in that it may be unilateral or bilateral and 
presents with sudden and intense vertigo that can affect gait and be accompanied by nausea and 
vomiting. In addition to vestibular symptoms, patients presenting with labyrinthitis will also 
report sudden hearing loss on the affected side (Thompson & Amedee, 2009).  
In the case of labyrinthitis, diagnosis is also one of exclusion. Due to the nature of the 
disease – be it viral or bacterial – steroids or antibiotics may be given. If treated promptly, 
permanent damage may be avoided (Shupert & Kulick, 2013). A baseline audiological 
evaluation should be performed as soon as possible to assess hearing loss. Routine evaluations to 
determine improvement or need for intervention (i.e. hearing instruments) should be 
recommended. In addition to hearing loss, vestibular symptoms should be treated in the same 
manner as vestibular neuritis. As with vestibular neuritis, anti-nausea and anti-vertigo 
medications may also be prescribed for patient comfort.  
LABYRINTHITIS  VESTIBULAR NEURITIS  
• Sudden vertigo that may be 
accompanied by nausea and vomiting  
• Sudden vertigo that may be 
accompanied by nausea and vomiting  
Table 7. Differentiating Labyrinthitis and Vestibular Neuritis    
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• Tinnitus 
• Aural fullness 
• Sudden hearing loss 
• Tinnitus 
• Aural fullness 
 
 
Acoustic Neuroma/Vestibular Schwannoma  
 Acoustic neuromas are the most common intracranial benign neoplasms. One in every 
100,000 people per year is affected (Thompson & Amedee, 2009). Acoustic neuromas may also 
be called Vestibular Schwannomas as they are the result of abnormal production of Schwann 
cells of the vestibular nerve. These tumors were previously thought to affect the superior 
vestibular nerve, but more recently research has shown that both the superior and inferior 
vestibular portions may be affected. Less than 5% of acoustic neuromas arise from the cochlear 
branch of the vestibulocochlear nerve (Khrais, Romano, Sanna, 2008).  
 There are two categories of acoustic neuromas, sporadic acoustic neuromas or acoustic 
neuromas associated with Neurofibromatosis Type II. Sporadic acoustic neuromas are more 
common, occur unilaterally and symptoms may not present until later in life. Neurofibromatosis 
Type II is associated with bilateral acoustic neuromas that present early in life – typically in the 
teenage years. According to West, Møller, Hansen and Cayé-Thomasen (2018), recent studies 
have shown that the incidence of sporadic acoustic neuromas is on the rise - an estimated 20 
cases per million persons per year.  
Although slow growing, as acoustic neuromas become larger, they can compress the 
facial, auditory and vestibular nerves.  Once compression begins, symptoms arise. As the tumor 
arises on the vestibular nerve, balance problems may be one of the first symptoms. However, due 
to the body’s ability to compensate – these balance symptoms may go unnoticed. While vertigo 
may be associated with a new and smaller tumor, this symptom abates with tumor 
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growth (Thompson & Amedee, 2009).  Instead, as the tumor grows in size, 
imbalance or disequilibrium becomes more prevalent.   
Hearing loss is typically progressive, unilateral high frequency sensorineural hearing loss 
that presents on the affected. Although typically slow growing, some tumors may grow at a rate 
that causes the tumor to cut off bloody supply rapidly causing a sudden hearing loss. Patients 
who present with sudden hearing loss should be treated with urgency. Imaging such as MRI is 
the gold standard in detecting an acoustic neuroma. Referral to neuro-otology and audiology will 
allow for baseline evaluations and appropriate treatment.  
 As with hearing loss, tinnitus is typically unilateral. Once large enough to compress the 
facial nerve or trigeminal nerve, patients may experience facial weakness or 
numbness. Diagnosis of acoustic neuroma includes a thorough history and audiological 
evaluation including hearing and balance assessments. In addition, imaging is recommended to 
confirm or rule out the presence of the neoplasm Magnetic Resonance Imaging is considered the 
gold standard.  Once confirmed, treatment options range from observation, radiation and surgical 
removal.   
Semicircular Canal Dehiscence  
 Semicircular canal dehiscence is also 
known as superior semicircular canal 
dehiscence (SSCD) given the nature of the 
disorder. SSDC is the thinning or absence of 
bone over the superior semicircular canal. 
This hole creates a third window in addition to 
the oval and round windows into the inner ear. 
Figure 11. Dehiscence of the superior 
semicircular canal.  
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This third window allows for the transfer of pressure and sound into the vestibular system 
(Thompson & Amedee, 2009).  This pressure in the vestibular system sets the vestibular 
endolymph into motion resulting in vestibular symptoms. 
 Patients may present with complaint of hearing their own voice or breath, aural fullness, 
vertigo and oscillopsia evoked by loud noises. This sensation of vertigo induced by sound is 
known as Tulio’s phenomenon. While frequently loud sounds are the cause of vertiginous 
episodes, it is not always true. In addition to Tulio’s phenomenon, Hennebert’s sign is another 
phenomenon associated with semicircular canal dehiscence in which pressure applied to the 
middle ear results in vertigo and nystagmus (Naert et al., 2017).  
In addition to vestibular symptoms, the third window also allows energy from air-
conducted sounds does not enter directly to the cochlea but instead is partially directed through 
the new hole in the semicircular canal which creates an apparent conductive hearing loss. The 
severity of the hearing loss is based on the location and size of the dehiscence (Zipser & 
Sepahdari, 2014). Hyperacusis, sensitivity to sounds, is also common.  
 As with all disorders, those with semicircular canal dehiscence may present with varying 
symptoms to varying degrees. The study by Naert et al. (2017) revealed that the five most 
frequently reported symptoms were spontaneous dizziness, Tulio’s phenomenon, hearing loss, 
autophony and Hennebert’s sign. Prior to diagnosis, it is recommended that an audiologist 
evaluate patients with suspected semicircular canal dehiscence. In addition to a hearing test, 
ocular vestibular evoked myogenic potentials are recommended. These evaluations combined 
with computerized tomography to detect the location of the dehiscence will allow for appropriate 
diagnosis. 
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DISORDER MOST COMMON 
SYMPTOMS 
REFERRALS TREATMENT 
BPPV Dizziness evoked by 
movement (i.e. rising 
from chair or rolling 
over in bed) 
ENT, Audiology, 
Physical Therapy 
if needed 
Canalith repositioning 
maneuver, vestibular 
rehabilitation therapy 
if needed  
Meniere’s Disease Aural fullness 
Tinnitus 
Hearing loss (typically 
begins as low 
frequency 
sensorineural hearing 
loss) 
Episodic vertigo 
ENT, Audiology, 
Physical Therapy 
Lifestyle 
modifications 
(CATSS), diuretics, 
anti-vert, anti-nausea, 
antihistamines, 
anticholinergics, 
vestibular neurectomy, 
labyrinthectomy, 
endolymphatic sac 
surgery, hearing 
instrument(s) 
Vestibular Neuritis Sudden onset 
dizziness 
Tinnitus 
Aural fullness 
ENT, Audiology, 
Physical Therapy 
Anti-vertigo, anti-
nausea, vestibular 
rehabilitation therapy 
Labyrinthitis Sudden onset 
dizziness 
Tinnitus 
Aural fullness 
Hearing loss 
ENT, Audiology, 
Physical Therapy 
Anti-vertigo, anti-
nausea, vestibular 
rehabilitation therapy, 
hearing instrument(s) 
Acoustic 
Neuroma/Vestibular 
Schwannoma  
Dizziness 
Unilateral tinnitus 
Unilateral aural 
fullness 
Unilateral hearing loss 
ENT, Audiology, 
Physical Therapy 
if symptoms 
worsen 
Observation, radiation, 
surgical removal, 
hearing instrument(s), 
vestibular 
rehabilitation if 
needed 
Semicircular Canal 
Dehiscence  
Dizziness 
Tulio’s Phenomenon 
Oscillopsia  
Autophony 
ENT, Audiology Limited treatment or 
management of 
symptoms, surgical 
option for severe cases 
  
Table 8. Overview of peripheral vestibular disorders     
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Central Vestibular Disorders 
Patients presenting with central vestibular disorders more typically present with 
imbalance or disequilibrium rather than “true vertigo.” That is, they may not experience a room 
spinning sensation. Patients with a central lesion are more likely to have difficulty ambulating – 
even with assistance – and their gait is notably impaired. Those with these disorders are likely to 
have a wide array of symptoms. A complete neurological evaluation should be done for 
appropriate diagnosis and treatment in addition to specialized evaluations. 
Vestibular Migraine  
 Migraines are commonly associated with severe headache, nausea, light sensitivity and 
sound sensitivity. Migraines are categorized as migraines with or without aura. Auras refer to 
neurological symptoms such as visual disturbances, changes in somatosensory, weakness, 
changes in smell and hearing, and dizziness. These typical migraines are reported to affect 10% 
of Americans, women more so than men (Thompson & Amedee, 2009). The onset of vestibular 
symptoms is reported to occur 8 to 19 years after migraines with or without auras begin. In 
postmenopausal women, vestibular migraines with imbalance, dizziness or true vertigo 
frequently occur without headaches (Luzeiro, Luis, Goncalves & Martins, 2017). 
Within the past few years, vestibular migraines have been recognized as an independent 
neurotologic disorder. Of patients that experience migraines, 30 to 50 percent are reported to 
experience vertigo (Luzeiro, Luis, Goncalves & Martins, 2017). The large range in percentage of 
those experiencing vertigo is the result of the variation between patients experiencing migraines. 
Uncertainty in localization and pathophysiology of migraines results in a wide array of clinical 
presentations.  
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Regardless of diagnostic evaluations available, no single approach is fit for all patients or 
for one patient over time. Patients with vestibular migraine may experience different symptoms 
with each episode (Furman & Balaban, 2015). Most commonly, vestibular symptoms present as 
an aura and can last seconds to hours. The characteristics of dizziness are endless. Some patients 
may report imbalance. Some patients may report room-spinning vertigo. Duration and severity of 
attacks are also patient-dependent (Furman & Balaban, 2015). 
Due to the above noted variations and similar symptomology as other vestibular 
disorders, vestibular migraine diagnosis is one of exclusion. To better diagnose and treat 
vestibular migraines, the International Headache Society and the Barany Society published 
criteria for identifying the disorder in 2013 (Luzeiro, Luis, Goncalves & Martins, 2017). The 
ICHD-3 Beta Diagnostic Criteria of Vestibular Migraine is listed below. As with all central 
vestibular disorders, a complete neurological evaluation is recommended in addition to vestibular 
evaluations. A comprehensive case history will be necessary for appropriate treatment. 
Treatment and management options often include lifestyle changes to avoid triggers. Stress 
relief, exercise and sleep may aid in this. Anti-nausea, anti-vertigo and no-steroidal anti-
inflammatory drugs (NSAIDS) may aid in relief of acute symptoms (Thompson & Amedee, 
2009). 
A At least five episodes filling criteria for (C) and (D) 
B Current or past history of migraine, either with or without aura, considering the International 
Classification of Headache Disorders (ICHD) criteria  
C Moderate or severe vestibular symptoms lasting 5 minutes to 72 hours 
D At least half of the episodes are associated with at least one of these migraines associated 
features: 
1. Headache with at least two of the following characteristics 
• Unilateral location 
• Pulsating quality 
• Moderate or severe intensity 
• Aggravation by routine physical activity  
Table 9. ICHD-3 Beta Diagnostic Criteria of Vestibular Migraine 
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2. Photophobia and phonophobia 
3. Visual aura  
E No other better diagnostic explanation  
 
Vertebrobasilar Ischemic Stroke 
 The vertebrobasilar system supplies blood to the brainstem, cerebellum and the inner ear. 
The three major branches are the posterior inferior cerebellar artery, the anterior inferior 
cerebellar artery and the superior cerebellar artery. Occlusion of any one of these major branches 
can result in vertigo.  Depending on the location of the lesion, symptoms will vary (Thompson & 
Amedee, 2009). Occlusion of the posterior inferior cerebellar artery results in lateral medullary 
infarction, which leads to lateral medullary syndrome also known as Wallenberg’s syndrome. 
Occlusion of the anterior inferior cerebellar artery results in lateral pontomedullary infarction. 
Occlusion of the superior cerebellar artery results in lateral superior pontine syndrome. A patient 
presenting with strictly vertiginous symptoms should be evaluated for a vertebrobasilar ischemic 
stroke. Evaluation should include a neurology consultation, physical evaluation and imaging 
(Thompson & Amedee, 2009).  
 
Lateral Medullary Infarction Lateral Pontomedullary 
Infarction  
Lateral Superior Pontine 
Syndrome 
• Vertigo 
• Nystagmus 
• Gait disturbance 
• Ipsilateral limb ataxia 
• Facial pain/numbness 
• Contralateral body 
hemianesthesia  
• Horner’s syndrome 
• Dysphagia  
• Hoarseness 
• Facial nerve paralysis 
(rare) 
• Similar symptoms to 
Wallenberg’s syndrome 
with the exception of 
hoarseness and dysphagia  
• Involvement of cranial 
nerves VII and VIII results 
in ipsilateral facial 
paralysis, tinnitus and 
hearing loss 
• Vertigo 
• Nystagmus 
• Gait disturbance 
• Ipsilateral limb ataxia 
• Facial pain/numbness 
• Contralateral body 
hemianesthesia  
• Horner’s syndrome 
• Contralateral impairment 
of vibration and 
temperature due to 
involvement of the medial 
lemniscus  
 
Table 10.  Classification of vertebrobasilar ischemic stroke 
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Vestibulotoxic Drugs 
Ototoxicity is the result of certain medications and/or chemicals that cause damage to the 
inner ear that leads to functional impairment and degeneration of the inner ear. Ototoxins can 
take the form of medications, heavy metals or chemical vapors. Iatrogenic ototoxicity occurs 
when a drug is administered in hopes of improving a person’s health. Unfortunately, the drug 
used to treat, prevent or diagnose the medical condition negatively affects other aspects of the 
person’s health (Myers, 2015).  
When determining the presence and cause of ototoxicity, an in-depth case history and 
medication history is helpful. Case history should pertain to conditions that could put the patient 
at risk for ototoxicity. This includes any general health problems, dehydration, sensitivity to 
medications and any past ototoxic reactions, such as tinnitus from a previous medication. 
Medication history questions should pertain to ototoxic agents. This includes any past ototoxic 
drug use, long history of medication use, and verification of appropriate dosage of previous and 
current medications. A list of past and current medications will be beneficial, especially those 
taken preceding a change in hearing or the development of tinnitus or vertigo (Myers, 2015). 
Ototoxic substances travel through the body. Once the substance has moved through the 
gastrointestinal system, the drug is completely absorbed into the bloodstream. When an ototoxic 
agent is present in the bloodstream, it enters the inner ear. The blood supply to the inner ear is 
critical for normal hearing and vestibular function. While the kidneys serve as the body’s 
eliminator of waste including ototoxic substances, the system is not fool proof and any problems 
with the kidneys will enhance ototoxic effects (Myers, 2015).  
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The physiological basis of ototoxicity refers to the mechanisms that cause auditory 
structures to die. These two basic mechanisms are programmed cell death (PCD) and necrosis. 
PCD is a naturally occurring action that involves a set of molecular events that have been 
programmed into the genetic nature of the cell. In other words, a genetic code that will determine 
how long a cell will live. Necrosis is the death of a structure and is usually caused from stress or 
damage. Necrosis can occur by mechanical means – such as high intensity noise exposure which 
causes damage in the first turn of the cochlea; lack of blood or nutrition, and/or exposure to toxic 
organisms, agents, or chemicals (Myers, 2015). 
Symptoms of ototoxicity vary depending if they are cochleotoxic (toxic to the cochlea) or 
vestibulotoxic (toxic to the vestibular system). Bilateral sensorineural hearing loss is a 
cochleotoxic effect. It can be temporary, but it is usually irreversible. The hearing loss can occur 
in various patterns, but the first signs usually occur in the extended high frequencies (above 8000 
Hz). Besides hearing loss, some drugs cause hearing to be distorted. The change in hearing 
should correspond with the start or increased dosage of the ototoxic drug. Whether or not the loss 
will be temporary or permanent is dependent on the causative agent and the dosage as ototoxicity 
is related to dosing levels. For example, high doses of aspirin can be ototoxic but small, 
occasional doses are not ototoxic. In addition to sensorineural hearing loss, tinnitus is also a 
cochleotoxic effect. Tinnitus is a very common effect and is the number one indicator of 
ototoxicity. Ototoxic substances can cause new tinnitus or exacerbate pre-existing tinnitus. 
Another symptom of cochleotoxicity is aural fullness (Myers, 2015). 
Vestibulotoxic effects may occur with or without cochleotoxicity. Vestibulotoxic effects 
are generally characterized by dizziness, vertigo, ataxia, nystagmus and/or oscillopsia. These 
balance disturbances are associated with aminoglycosides, antimalarial drugs, antineoplastic 
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drugs, and loop diuretics. Vestibulotoxic symptoms can occur due to therapeutic vestibular 
ototoxicity. These are ototoxic drugs introduced to reduce the effects of vestibular pathologies, 
such as Gentamicin – an aminoglycoside – used for treatment of endolymphatic hydrops.  
Listed below is information regarding commonly prescribed and known ototoxic agents. 
Information has been adapted from Dr. Michael Meyers, AuD.  
Aminoglycosides  
Along with Gentamycin, other aminoglycosides are known ototoxic drugs. 
Aminoglycosides are antibiotics used to rid the body of bacteria in life threatening situations. 
The overall incidence of ototoxicity for patients taking aminoglycosides is 8 percent (Love, 
VandeWaa, DeRuiter & Ramachandran, 2013). When aminoglycosides are administered orally 
or topically they are not typically ototoxic. IV and injection aminoglycosides, however, can be 
ototoxic. These substances are cochleo-vestibulotoxic (affecting both the auditory and vestibular 
systems) and the effects are usually not reversible. Aminoglycosides such as Streptomycin and 
Gentamicin are primarily vestibulotoxic. Neomycin, Amikacin, and Kanamycin are primarily 
cochleotoxic. Tobramycin has the potential for cochlear and vestibular damage. With multiple 
aminoglycoside treatments, the patient is at an increased risk during the additional rounds.  
Loop Diuretics  
Loop diuretics are used to remove excess fluid. When administered orally, there is a low 
ototoxic risk. When administered intravenously, there is a high ototoxic risk. Ototoxic effects are 
almost instantaneously and may occur within minutes after administration of high doses or rapid 
IV infusion (Love, VandeWaa, DeRuiter & Ramachandran, 2013). Fortunately, these effects 
typically recover within 24-72 hours of final dosing. Loop diuretics have cochlea-vestibulotoxic 
effects. Usually, the hearing loss will resolve within 24-48 hours. Occasionally vestibular 
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symptoms occur. Examples of ototoxic loop diuretics include Furosemide, Bumetaside, 
Ethracrynic acid, and Torsemide. If aminoglycosides are given first within 8 hours of loop 
diuretics, there is an increased ototoxic effect since aminoglycosides affect cell permeability. 
Non-steroidal Anti-Inflammatory Drugs 
Non-steroidal Anti-Inflammatory Drugs (NSAIDS) are another family of ototoxic drugs. 
These are used as pain relievers, fever reducers and as salicylates. NSAIDS are administered 
orally and have cochlea-vestibulotoxic effects that are typically reversible. Hearing loss from 
NSAIDS is typically high frequency but may be flat. Ototoxic effects are dose related and effects 
disappear 24-72 hours after discontinuing use of the medication. Examples of NSAIDS include 
salicylates, ibuprofen, naproxen, indomethacin, and acetaminophen. Abuse of Vicodin 
(acetaminophen and codeine) may result in irreversible, profound hearing loss. 
Chemotherapeutic Agents 
Chemotherapeutic agents such as Cisplatin, Carboplatin, Vinblastine and Vincristine are 
known ototoxins. Platinum based anti-neoplastic agents carry the most ototoxic effects, which 
are not usually reversible. These are intravenous drugs used in oncologic treatments. Ototoxic 
effects are dose and age related. Those 5 years old and under and those above 46 years of age 
have a higher risk of susceptibility. These agents primarily cause outer hair cell damage and 
often tinnitus, which can be transient.  
Anti-malarials 
Anti-malarials such as quinine have effects similar to aspirin and they are usually 
reversible with discontinuation. Cinchonism is a syndrome resulting from Quinine that leads to 
hearing loss, dizziness, headaches, nausea, and vision changes. Organic solvents such as styrene, 
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toluene, trichloroethylene, and butyl nitrate are known ototoxic chemicals. Janitors, assemblers, 
printing machine operators and laundromat workers are all at risk to these chemicals. Lastly, 
heavy metals such as mercury, manganese, and lead can be ototoxic.   
MEDICATION CLASSIFICATION PRIMARY 
OTOTOXICITY 
PERMANENT OR 
REVERSIBLE 
Acetaminophen  NSAID Cochleo-vestibulotoxic Reversible 
Amikacin Antibiotic Cochleotoxic Permanent 
Bumetaside Diuretic Cochleo-vestibulotoxic Reversible 
Carboplatin Chemotherapy agent Cochleotoxic Permanent 
Cisplatin Chemotherapy agent Cochleotoxic  Permanent 
Ethracrynic acid Diuretic Cochleo-vestibulotoxic Reversible 
Furosemide Diuretic  Cochleo-vestibulotoxic Reversible 
Gentamicin  Antibiotic Vestibulotoxic Permanent 
Ibuprofen NSAID Cochleo-vestibulotoxic Reversible 
Indomethacin NSAID Cochleo-vestibulotoxic Reversible 
Kanamycin Antibiotic Cochleotoxic Permanent 
Naproxen NSAID Cochleo-vestibulotoxic Reversible 
Neomycin Antibiotic Cochleotoxic  Permanent 
Quinine Anti-malarial  Cochleo-vestibulotoxic Reversible  
Salicylates NSAID Cochleo-vestibulotoxic Reversible 
Streptomycin Antibiotic  Vestibulotoxic  Permanent 
Tobramycin Antibiotic Cochleo-vestibulotoxic Permanent 
Torsemide Diuretic Cochleo-vestibulotoxic Reversible 
Vancomycin Antibiotic Cochlea-vestibulotoxic  Permanent  
Table 11.  Classification of common ototoxic medications  
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Vicodin NSAID Cochleo-vestibulotoxic  Permanent  
Vinblastine Chemotherapy agent Cochleotoxic Permanent 
Vincristine Chemotherapy agent Cochleotoxic Permanent 
 
Vestibulotoxic effects are harder to monitor than cochleotoxic effects. Vestibular results 
are highly variable and there is no standard baseline or monitoring protocol. Bedside testing 
including head shake nystagmus, head thrust testing, dynamic visual acuity, and postural control 
can be done but it is difficult. Laboratory testing such as 
electronystagmography/videonystagmography (ENG/VNG), rotary chair, and dynamic 
posturography can also be done in an attempt to monitor vestibular effects. In order to properly 
monitor ototoxicity, a multidiscipline approach should be used. This involves various 
instruments, coordination of efforts between different health professionals, patient factors, and 
costs.  
Several ototoxic risk factors have been identified that increase ototoxic effects. Certain 
genetic anomalies can cause aminoglycoside antibiotics to recognize genes as bacteria, which 
causes hearing loss. Grapefruit juice is another risk factor as it can prevent the breakdown of 
certain medication, which causes medications to stay in their unbroken state and in the body for 
an extended time. The liver won’t metabolize the way it should which causes increased ototoxic 
effects. Polypharmacy can increase ototoxic effects. As we age, risk for ototoxicity occurs due to 
a slowing metabolism, increased likelihood of polypharmacy and malnourishment. Lastly, noise 
is a risk factor. Exposure to noise during or after some drug treatment or chemical exposure can 
be synergistic. Ways to reduce ototoxicity risk factors include: discussing medication effects 
with doctors, following dosage instructions, awareness of ototoxicity signs, informing physician 
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of pre-existing cochlear, vestibular, and/or renal issues, avoiding dehydration, avoiding 
polypharmacy, avoiding noisy environments, establishing audiometric/vestibular function 
baseline, and if chemotherapy is necessary – administer chemotherapy drugs before radiation to 
reduce ototoxic risk.  
As healthcare professionals, the goal should be to prevent cell death in the auditory 
system to maintain a promising quality of life for our aging patient population. This can be done 
with treatments, rehabilitation, and prevention techniques. Additionally, early identification will 
play a role in the prevention of cell death. With early identification, it is possible to treat a 
condition with less ototoxic medications. To do this, healthcare professionals need to create 
relationships with hearing healthcare professionals – such as audiologists or otolaryngologists – 
to exchange information and to provide referrals in regard to any auditory or vestibular changes 
from medications. Additionally, if warranted, in-service education by an audiologist can aid in 
building a team approach to prevent ototoxic effects.  
Unfortunately, early identification can only go so far. Depending on the condition, less 
ototoxic medication is not always an option. In this situation, early intervention can help prevent 
the progression of ototoxic effects. It is important to maintain communication with your patients 
and an audiologist as ototoxic effects progress. Rehabilitation programs can be effective to 
prepare the patient and create a proactive program for the progression.  
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Appendices  
 
The information presented in this healthcare guide is provided to increase awareness of 
vestibular degeneration and dysfunction in the aging population. Below are additional handouts 
and questionnaires to be implemented into your daily practice should you encounter the dizzy 
patient. 
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What causes vertigo? 
Balance problems  
Heart disease 
Anxiety 
Medication 
Head trauma 
Infection/Virus 
Diabetes 
Stroke 
& many more!  
 
Appendix A. Vertigo handout 
 
  SPINNING OUT OF CONTROL 
WHEN A SYMPTOM BECOMES UNSAFE 
What is vertigo? 
The feeling that oneself or the room is spinning. It is a 
symptom – not a disease. 
 
 
 
 
 
 
 
  
  
 
Is vertigo dangerous? 
Did you ever spin around in circles as a child and fall over? 
Vertigo is like that – except without the fun and games.  It 
can be harmless but it can also be harmful if it causes to falls. 
Falls can be minor and result in bumps and bruises or they 
can be major and result in broken bones and even death.   
Who has vertigo?  
40% of the US population 
will likely suffer from a 
dizziness or balance 
problem in their lifetime 
 
69 million Americans age 
40+ suffer from vertigo 
related to some type of 
vestibular disorder 
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SPINNING OUT OF CONTROL 
TIPS TO STAY SAFE & PREVENT FALLS 
Talk to your doctor 
An apple a day may keep the doctor away, but it won’t save you from a bad 
fall. Talk to your doctor about your risk factors and what you can do to 
prevent falling. They can give you information about local fall safety programs. 
Manage your medications 
Ask your doctor if there are any side effects that could increase your risk of 
falling. 
Get your eyes & ears checked 
Your eyes and ears help you to see and hear any danger.  They also help you 
keep your balance. Make sure to take care of both and schedule yearly check-
ups. 
Get moving! 
Join a local workout program to build strength and improve balance. 
Make your home safe 
Make sure every room has bright lighting. Pick up clutter to reduce tripping 
hazards. Install stair railings. Use non-slip mats in the bathroom.  Mark steps 
with caution tape. Simple changes can make a big difference. 
Talk to your friends & family 
Falls can cause harm that other cannot see. Fear of falling can cause stress and 
harmful feelings. Don’t keep these feelings to yourself. Talking to a loved one 
can help you cope with what you are going through. Support can help keep 
you safe. 
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Appendix B. Dizziness Handicap Inventory 
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Appendix C. Initial Referral Guide Based on Primary Symptom  
 
   
 
 
 
Sudden hearing loss
Emergency Dept. & Audiology
Refer for imaging (MRI,CT) & 
baseline hearing test
Hearing Loss 
Audiology
Refer for Hearing 
Evaluation 
Vertigo
ENT &Audiology
Refer for estibular 
evaluation: VNG, 
cVEMP, oVEMP, vHIT
Tinnitus
ENT & Audiology
Refer for hearing evaluation, 
tinnitus evaluation, possible 
imaging
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Migraine
Neurology
Refer for neurological 
evaluation & possible 
imaging (MRI/CT)
Ear pain
ENT
Refer for 
otologic 
evaluation
Ear drainage
ENT
Refer for 
otologic 
evaluation
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